Organophosphate poisoning is poisoning due to organophosphates (OPs). Organophosphates are used as insecticides, medications, and nerve agents.
Symptoms include increased saliva and tear production, diarrhea, vomiting, small pupils, sweating, muscle tremors, and confusion.
Other names: Organophosphate toxicity
Causes: organophosphates
Post-operative apnoea fortunately rare can catch the anaesthetist off guard. A through knowledge is needed to make a quick differential diagnosis to correct the problem leading to prolonged apnoea
Organophosphate poisoning is poisoning due to organophosphates (OPs). Organophosphates are used as insecticides, medications, and nerve agents.
Symptoms include increased saliva and tear production, diarrhea, vomiting, small pupils, sweating, muscle tremors, and confusion.
Other names: Organophosphate toxicity
Causes: organophosphates
Post-operative apnoea fortunately rare can catch the anaesthetist off guard. A through knowledge is needed to make a quick differential diagnosis to correct the problem leading to prolonged apnoea
This ppt tells about OPI poisoning in animals. Insecticide poisoning is a serious issue in Veterinary practice. This ppt tries to cover in detail all aspects of OP insecticide poisoning in animals.
This ppt tells about OPI poisoning in animals. Insecticide poisoning is a serious issue in Veterinary practice. This ppt tries to cover in detail all aspects of OP insecticide poisoning in animals.
Organophosphate poisoning national guidelinecharithwg
publication by Dr-C.Here the given information are based on recommendations by sri lankan medical specialists who have dealt with the issue for a long time. it is quite obvious using agro chemical to deliberate self harm is a tendency in developing countries. it is common in agricultural ares.all the information are correct according to my knowledge. all the materials used to publish the slideshow are international publications. you have the full right to download and read. my personal request is to submit your ideas to me. and suggest different topics. i like to see your responses. i hope you would manage patients like these some day though it is so sad to see such incidents. be confident. do good. do not harm. be kind. keep us in your memories.
Similar to Organophosphorus_Poisoning_final.pptx (20)
Refers to cardiac muscle that is alive, not dead presence of cellular, metabolic, and microscopic contractile function Clinically LV systolic dysfunction in ischemic heart disease does not always represent irreversible damage and dysfunctional but viable myocardium has the potential to improve its systolic function after revascularization Two basic mechanisms of reversible ischemic dysfunction myocardial stunning myocardial hibernation
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
4. Common OP pesticides with their brands
available in Nepal
OP pesticide Brands available
Methyl parathion Metacid, Parahit, Paradol
Dichlorovos Nuvan, DDVP, Nudan, Suchlor
Dimethoate Rogor, Roger, Rogohit
Chlorpyrifos Durmet, Dhanuban, Radar
Fenthion Dalf, Baytex
Profenofos Current
Quinalphos Krush
Monocrotophos Phoskill
8. AGEING
Irreversible inhibition of acetylcholinesterase due to phosphorylation
of the active site of the enzyme(serine hydroxl group) and with time
the enzyme-OP complex loses one alkyl group making it no longer
responsive to reactivating agents.
Ageing time
Dimethyl – 3.7 hours
Diethyl – 31 hours
Nerve agents – within minutes
Carbamate-no ageing
Spontaneous reactivation half life
Dimethyl - 0.7hours
Diethyl - 31 hours
Carbamate-30-40 minutes
11. Muscarinic effects(parasympathetic)
D iarrhoea, Abdominal cramps
U rinary incontinence
M iosis
B radycardia, Hypotension, Ventricular tachycardia
E mesis
L acrimation
S alivation
Pulmonary oedema, bhronchospasm, bronchorrhea
15. Intermediate syndrome
Usually occurs after 24 to 96 hours of ingestion.
last up to 5-14 days
Approximately 10-40% of patients develop this
illness.
Characterized by prominent weakness ocular
muscles to neck flexors, muscles of respiration
and proximal limb muscles.
Require ventilatory care.
16. DELAYED POLYNEUROPATHY (OPIDN)
Uncommon consequence of severe intoxication or intermittent and
chronic contact
Due to inhibition of neuropathy target esterase (NTE) enzyme in
nervous tissues
Chlorpyrifos(Durmet, Dhanuban, Radar) causes comparatively more
degree of inhibition of NTE
Clinical manifestations are of distal symmetric sensory-motor
polyneuropathy (muscle cramp, distal weakness, parasthesia, ataxia,
diminished or absent reflexes, flaccid paralysis)
usually begin 2-5 weeks after exposure and may last for years.
No specific therapy but regular physiotherapy may limit the deformity.
18. DIAGNOSIS
History of exposure to OP compounds.
Characteristics manifestations like Pinpoint pupil, Muscle
fasciculation, characteristic (garlic) smell of stomach aspirate
In case of doubt atropine challenge test can be done
1-2mg iv atropine is given, if it doesn’t produce dry skin,
dry mucosa, tachycardia and mydriasis in 15-20 minutes patient
has to be treated in the line of OP.
19. LAB TEST
Limited value as treatment is usually required before test results are
available
Level of plasma (pseudo) cholinesterase drops to less than 50%( Normal
value 3000-6000IU/L)
Clinical severity has been graded on the basis of the pseudocholinesterase level
Mild 20-50% enzyme activity
Moderate 10-20% enzyme activity and
Severe <10% enzyme activity
NB: True or erythrocyte cholinesterase correlates well with clinical severity but
is not available in most centres
21. General supportive treatment
1. Assessment of airways, breathing, and circulation
Comatose or vomiting patients should be kept in lateral positioning and
consider of placement of Guedel’s airway or ET intubation.
Frequent suctioning is essential as excessive oropharyngeal and respiratory
secretions may occlude the airway.
Oxygen is needed in majority of these patients; and this can be assessed by
frequent assessment of arterial oxygen saturation.
22. 2. Decontamination
The clothes should be removed and the skin
vigorously washed with soap and water.
NB: Always remember to wear gloves so as to prevent
skin absorption of the poison.
23. 3. Gastric lavage
Should be considered in patients presenting within 1-2
hours of ingestion of poison
Risks of gastric lavage include :
Aspiration
Hypoxia
Laryngeal spasm
Administer activated charcoal 100gm(aprox. 1gm/kg) in 200-
500ml of water.
24. Specific Antidotal Treatment
Atropine
Has been cornerstone in the management of OP poisoning
Atropine only blocks muscarinic effects whereas oximes reverse
both the nicotinic and muscarinic effects
MOA: competitively at the peripheral and central muscarinic
receptors and antagonizes the parasympathetic effects of excess
Ach.
25. Target end-points for Atropine therapy
Heart rate >80/ min
Dilated pupils
Dry axillae
Systolic blood pressure >80 mm Hg
Clear chest with absence of wheeze
26. HOW MUCH ATROPINE???
Initial bolus of 3-5 ampoules of atropine (each
ampoule containing 0.6 mg)
Subsequent doses doubled every 5 minutes until
atropinization is achieved
When the patient achieves most of (at least 4 out of 5)
the target end-points for atropine therapy i.e. fully
atropinized
28. INFUSION ATROPINE
10% of initial atropinizing dose per hour for first 24 hours
Reduce by 20-30% every day of initial dose
Tapper in this manner for 5 days
Reduce dose if features of toxicity develop
29. What if you give too much ATROPINE?
Hot as Hell
Blind as a Bat
Red as a Beet
Dry as a Bone
Mad as a hatter
That means hyperthermia, tachycardia, tremer,
restlessness, confusion, agitation, seizures
30. Oximes
Oximes work by reactivating acetylcholinesterase that has been
bound to the OP molecule
Eg. Pralodoxime(frequently used), obidoxime
WHO recommended pralidoxime dose of
30 mg/kg bolus iv over 10-20 minutes followed by continuous
infusion of 8-10 mg/kg/hour till atropine no longer required or 7 days
(whichever later)
Not recommended for carbamates
31. Benzodiazepines:
Diazepam and other benzodiazepines are widely used
for the treatment of OP induced seizures and
restlessness and agitation
32. Pregnancy
ingested OP insecticides during the second or third
trimester of pregnancy have been treated successfully
with atropine and pralidoxime
33. Diet
Nill per oral during atropinization
Once peristalsis sounds are heard start oral fluids and
gradually shift to soft food
34. Newer forms of therapies in OP
poisoning
Sodium bicarbonate
Adrenergic receptor α2 agonists like clonidine
Magnesium sulphate
Fresh frozen plasma
Antioxidants
Organophosphorus hydrolases
Galyclidine (NMDA receptor antagonist)